Skip to main navigation
Skip to search
Skip to main content
Universitas Indonesia Home
Search content at Universitas Indonesia
Home
Profiles
Research Groups
Research output
Facility
Projects/Grants
Activities
Press/Media
Acute Limb Ischemia in COVID-19: A Systematic Review
Suci Indriani
, Mohamed Amshar
, Raka Aldy Nugraha
, Taofan Siddiq
,
Suko Adiarto
Department of Cardiology and Vascular Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Acute Limb Ischemia in COVID-19: A Systematic Review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Limb Ischemia
100%
Amputation
9%
Amputation Rate
9%
C-reactive Protein
9%
Cause of Death
9%
Clinical Features
9%
Coagulation Parameters
9%
Cochrane
9%
Comorbidity
9%
Conservative Treatment
9%
COVID-19
100%
COVID-19 Pandemic
9%
D-dimer
9%
Data Extraction
9%
Data Pooling
9%
Factor Parameters
9%
Hypercoagulability
9%
Hypertension
9%
Inflammatory Parameters
9%
Ischemia Disease
9%
Limb Amputation
9%
Lower Limb
9%
Mortality Rate
9%
Overall Mortality
9%
Poor Outcome
9%
Popliteal Artery
9%
Post-coronavirus
9%
PubMed
9%
Respiratory Failure
9%
Risk Factors
9%
ScienceDirect
9%
Severe Coronavirus Disease 2019
9%
Study Support
9%
Therapy Outcome
9%
Thromboembolectomy
9%
Thrombosis
18%
Treatment Outcome
9%
Treatment Strategy
9%
Variables of Interest
9%
Medicine and Dentistry
Amputation
9%
Blood Clotting Factor
9%
C Reactive Protein
9%
Clinical Feature
9%
Comorbidity
9%
Conservative Treatment
9%
COVID-19
100%
Critical Limb Ischemia
100%
D-Dimer
9%
Hypercoagulability
9%
Limb Amputation
9%
Lower Limb
9%
Mortality Rate
9%
Pandemic
9%
Popliteal Artery
9%
Respiratory Failure
9%
Surgical Thrombectomy
9%
Systematic Review
100%
Thrombosis
18%
Pharmacology, Toxicology and Pharmaceutical Science
Blood Clotting Factor
9%
C Reactive Protein
9%
Clinical Feature
9%
Comorbidity
9%
Coronavirinae
100%
Critical Limb Ischemia
100%
D Dimer
9%
Diseases
100%
Hypercoagulability
9%
Mortality Rate
9%
Pandemic
9%
Respiratory Failure
9%
Thrombosis
18%